Viewing Study NCT05427305


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT05427305
Status: COMPLETED
Last Update Posted: 2022-06-22
First Post: 2022-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TAB008 Compared to AvastinĀ® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer
Sponsor: BioDlink Biopharm Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module